Global Radioactive Medical Isotopes Supply, Demand and Key Producers, 2024-2030

Page: 103

Published Date: 15 Aug 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Radioactive Medical Isotopes market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global Radioactive Medical Isotopes demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radioactive Medical Isotopes, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radioactive Medical Isotopes that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radioactive Medical Isotopes total market, 2019-2030, (USD Million)
Global Radioactive Medical Isotopes total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Radioactive Medical Isotopes total market, key domestic companies, and share, (USD Million)
Global Radioactive Medical Isotopes revenue by player, revenue and market share 2019-2024, (USD Million)
Global Radioactive Medical Isotopes total market by Type, CAGR, 2019-2030, (USD Million)
Global Radioactive Medical Isotopes total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Radioactive Medical Isotopes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Radioactive Medical Isotopes market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Radioactive Medical Isotopes Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Radioactive Medical Isotopes Market, Segmentation by Type
    Carbon-14
    Technetium-99m
    Iodine-131
    Iodine-125
    Others

Global Radioactive Medical Isotopes Market, Segmentation by Application:
    Diagnosis
    Treatment
    Others

Companies Profiled:
    NRG
    NTP Radioisotopes
    JSC Isotope
    ANSTO
    China National Nuclear Corporation (CNNC)
    IRE ELIT
    Nordion
    Polatom

Key Questions Answered
1. How big is the global Radioactive Medical Isotopes market?
2. What is the demand of the global Radioactive Medical Isotopes market?
3. What is the year over year growth of the global Radioactive Medical Isotopes market?
4. What is the total value of the global Radioactive Medical Isotopes market?
5. Who are the Major Players in the global Radioactive Medical Isotopes market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Radioactive Medical Isotopes Introduction
    1.2 World Radioactive Medical Isotopes Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Radioactive Medical Isotopes Total Market by Region (by Headquarter Location)
        1.3.1 World Radioactive Medical Isotopes Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.3 China Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.4 Europe Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.5 Japan Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.6 South Korea Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.7 ASEAN Based Company Radioactive Medical Isotopes Revenue (2019-2030)
        1.3.8 India Based Company Radioactive Medical Isotopes Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Radioactive Medical Isotopes Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.2 World Radioactive Medical Isotopes Consumption Value by Region
        2.2.1 World Radioactive Medical Isotopes Consumption Value by Region (2019-2024)
        2.2.2 World Radioactive Medical Isotopes Consumption Value Forecast by Region (2025-2030)
    2.3 United States Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.4 China Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.5 Europe Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.6 Japan Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.7 South Korea Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.8 ASEAN Radioactive Medical Isotopes Consumption Value (2019-2030)
    2.9 India Radioactive Medical Isotopes Consumption Value (2019-2030)

3 World Radioactive Medical Isotopes Companies Competitive Analysis
    3.1 World Radioactive Medical Isotopes Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Radioactive Medical Isotopes Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Radioactive Medical Isotopes in 2023
        3.2.3 Global Concentration Ratios (CR8) for Radioactive Medical Isotopes in 2023
    3.3 Radioactive Medical Isotopes Company Evaluation Quadrant
    3.4 Radioactive Medical Isotopes Market: Overall Company Footprint Analysis
        3.4.1 Radioactive Medical Isotopes Market: Region Footprint
        3.4.2 Radioactive Medical Isotopes Market: Company Product Type Footprint
        3.4.3 Radioactive Medical Isotopes Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Radioactive Medical Isotopes Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Radioactive Medical Isotopes Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Radioactive Medical Isotopes Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Radioactive Medical Isotopes Consumption Value Comparison
        4.2.1 United States VS China: Radioactive Medical Isotopes Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Radioactive Medical Isotopes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Radioactive Medical Isotopes Companies and Market Share, 2019-2024
        4.3.1 United States Based Radioactive Medical Isotopes Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Radioactive Medical Isotopes Revenue, (2019-2024)
    4.4 China Based Companies Radioactive Medical Isotopes Revenue and Market Share, 2019-2024
        4.4.1 China Based Radioactive Medical Isotopes Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Radioactive Medical Isotopes Revenue, (2019-2024)
    4.5 Rest of World Based Radioactive Medical Isotopes Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Radioactive Medical Isotopes Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Radioactive Medical Isotopes Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Radioactive Medical Isotopes Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Carbon-14
        5.2.2 Technetium-99m
        5.2.3 Iodine-131
        5.2.4 Iodine-125
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Radioactive Medical Isotopes Market Size by Type (2019-2024)
        5.3.2 World Radioactive Medical Isotopes Market Size by Type (2025-2030)
        5.3.3 World Radioactive Medical Isotopes Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World Radioactive Medical Isotopes Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Diagnosis
        6.2.2 Treatment
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Radioactive Medical Isotopes Market Size by Application (2019-2024)
        6.3.2 World Radioactive Medical Isotopes Market Size by Application (2025-2030)
        6.3.3 World Radioactive Medical Isotopes Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 NRG
        7.1.1 NRG Details
        7.1.2 NRG Major Business
        7.1.3 NRG Radioactive Medical Isotopes Product and Services
        7.1.4 NRG Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 NRG Recent Developments/Updates
        7.1.6 NRG Competitive Strengths & Weaknesses
    7.2 NTP Radioisotopes
        7.2.1 NTP Radioisotopes Details
        7.2.2 NTP Radioisotopes Major Business
        7.2.3 NTP Radioisotopes Radioactive Medical Isotopes Product and Services
        7.2.4 NTP Radioisotopes Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 NTP Radioisotopes Recent Developments/Updates
        7.2.6 NTP Radioisotopes Competitive Strengths & Weaknesses
    7.3 JSC Isotope
        7.3.1 JSC Isotope Details
        7.3.2 JSC Isotope Major Business
        7.3.3 JSC Isotope Radioactive Medical Isotopes Product and Services
        7.3.4 JSC Isotope Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 JSC Isotope Recent Developments/Updates
        7.3.6 JSC Isotope Competitive Strengths & Weaknesses
    7.4 ANSTO
        7.4.1 ANSTO Details
        7.4.2 ANSTO Major Business
        7.4.3 ANSTO Radioactive Medical Isotopes Product and Services
        7.4.4 ANSTO Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 ANSTO Recent Developments/Updates
        7.4.6 ANSTO Competitive Strengths & Weaknesses
    7.5 China National Nuclear Corporation (CNNC)
        7.5.1 China National Nuclear Corporation (CNNC) Details
        7.5.2 China National Nuclear Corporation (CNNC) Major Business
        7.5.3 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product and Services
        7.5.4 China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 China National Nuclear Corporation (CNNC) Recent Developments/Updates
        7.5.6 China National Nuclear Corporation (CNNC) Competitive Strengths & Weaknesses
    7.6 IRE ELIT
        7.6.1 IRE ELIT Details
        7.6.2 IRE ELIT Major Business
        7.6.3 IRE ELIT Radioactive Medical Isotopes Product and Services
        7.6.4 IRE ELIT Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 IRE ELIT Recent Developments/Updates
        7.6.6 IRE ELIT Competitive Strengths & Weaknesses
    7.7 Nordion
        7.7.1 Nordion Details
        7.7.2 Nordion Major Business
        7.7.3 Nordion Radioactive Medical Isotopes Product and Services
        7.7.4 Nordion Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Nordion Recent Developments/Updates
        7.7.6 Nordion Competitive Strengths & Weaknesses
    7.8 Polatom
        7.8.1 Polatom Details
        7.8.2 Polatom Major Business
        7.8.3 Polatom Radioactive Medical Isotopes Product and Services
        7.8.4 Polatom Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Polatom Recent Developments/Updates
        7.8.6 Polatom Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Radioactive Medical Isotopes Industry Chain
    8.2 Radioactive Medical Isotopes Upstream Analysis
    8.3 Radioactive Medical Isotopes Midstream Analysis
    8.4 Radioactive Medical Isotopes Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Radioactive Medical Isotopes Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Radioactive Medical Isotopes Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Radioactive Medical Isotopes Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Radioactive Medical Isotopes Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Radioactive Medical Isotopes Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Radioactive Medical Isotopes Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Radioactive Medical Isotopes Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Radioactive Medical Isotopes Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Radioactive Medical Isotopes Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Radioactive Medical Isotopes Players in 2023
 Table 12. World Radioactive Medical Isotopes Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Radioactive Medical Isotopes Company Evaluation Quadrant
 Table 14. Head Office of Key Radioactive Medical Isotopes Players
 Table 15. Radioactive Medical Isotopes Market: Company Product Type Footprint
 Table 16. Radioactive Medical Isotopes Market: Company Product Application Footprint
 Table 17. Radioactive Medical Isotopes Mergers & Acquisitions Activity
 Table 18. United States VS China Radioactive Medical Isotopes Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Radioactive Medical Isotopes Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Radioactive Medical Isotopes Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Radioactive Medical Isotopes Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Radioactive Medical Isotopes Revenue Market Share (2019-2024)
 Table 23. China Based Radioactive Medical Isotopes Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Radioactive Medical Isotopes Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Radioactive Medical Isotopes Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Radioactive Medical Isotopes Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Radioactive Medical Isotopes Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Radioactive Medical Isotopes Revenue Market Share (2019-2024)
 Table 29. World Radioactive Medical Isotopes Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Radioactive Medical Isotopes Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Radioactive Medical Isotopes Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Radioactive Medical Isotopes Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World Radioactive Medical Isotopes Market Size by Application (2019-2024) & (USD Million)
 Table 34. World Radioactive Medical Isotopes Market Size by Application (2025-2030) & (USD Million)
 Table 35. NRG Basic Information, Manufacturing Base and Competitors
 Table 36. NRG Major Business
 Table 37. NRG Radioactive Medical Isotopes Product and Services
 Table 38. NRG Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. NRG Recent Developments/Updates
 Table 40. NRG Competitive Strengths & Weaknesses
 Table 41. NTP Radioisotopes Basic Information, Manufacturing Base and Competitors
 Table 42. NTP Radioisotopes Major Business
 Table 43. NTP Radioisotopes Radioactive Medical Isotopes Product and Services
 Table 44. NTP Radioisotopes Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. NTP Radioisotopes Recent Developments/Updates
 Table 46. NTP Radioisotopes Competitive Strengths & Weaknesses
 Table 47. JSC Isotope Basic Information, Manufacturing Base and Competitors
 Table 48. JSC Isotope Major Business
 Table 49. JSC Isotope Radioactive Medical Isotopes Product and Services
 Table 50. JSC Isotope Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. JSC Isotope Recent Developments/Updates
 Table 52. JSC Isotope Competitive Strengths & Weaknesses
 Table 53. ANSTO Basic Information, Manufacturing Base and Competitors
 Table 54. ANSTO Major Business
 Table 55. ANSTO Radioactive Medical Isotopes Product and Services
 Table 56. ANSTO Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. ANSTO Recent Developments/Updates
 Table 58. ANSTO Competitive Strengths & Weaknesses
 Table 59. China National Nuclear Corporation (CNNC) Basic Information, Manufacturing Base and Competitors
 Table 60. China National Nuclear Corporation (CNNC) Major Business
 Table 61. China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Product and Services
 Table 62. China National Nuclear Corporation (CNNC) Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. China National Nuclear Corporation (CNNC) Recent Developments/Updates
 Table 64. China National Nuclear Corporation (CNNC) Competitive Strengths & Weaknesses
 Table 65. IRE ELIT Basic Information, Manufacturing Base and Competitors
 Table 66. IRE ELIT Major Business
 Table 67. IRE ELIT Radioactive Medical Isotopes Product and Services
 Table 68. IRE ELIT Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. IRE ELIT Recent Developments/Updates
 Table 70. IRE ELIT Competitive Strengths & Weaknesses
 Table 71. Nordion Basic Information, Manufacturing Base and Competitors
 Table 72. Nordion Major Business
 Table 73. Nordion Radioactive Medical Isotopes Product and Services
 Table 74. Nordion Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Nordion Recent Developments/Updates
 Table 76. Nordion Competitive Strengths & Weaknesses
 Table 77. Polatom Basic Information, Manufacturing Base and Competitors
 Table 78. Polatom Major Business
 Table 79. Polatom Radioactive Medical Isotopes Product and Services
 Table 80. Polatom Radioactive Medical Isotopes Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Polatom Recent Developments/Updates
 Table 82. Polatom Competitive Strengths & Weaknesses
 Table 83. Global Key Players of Radioactive Medical Isotopes Upstream (Raw Materials)
 Table 84. Global Radioactive Medical Isotopes Typical Customers


List of Figures
 Figure 1. Radioactive Medical Isotopes Picture
 Figure 2. World Radioactive Medical Isotopes Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Radioactive Medical Isotopes Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Radioactive Medical Isotopes Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Radioactive Medical Isotopes Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Radioactive Medical Isotopes Revenue (2019-2030) & (USD Million)
 Figure 13. Radioactive Medical Isotopes Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Radioactive Medical Isotopes Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Radioactive Medical Isotopes Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Radioactive Medical Isotopes by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Radioactive Medical Isotopes Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Radioactive Medical Isotopes Markets in 2023
 Figure 27. United States VS China: Radioactive Medical Isotopes Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Radioactive Medical Isotopes Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Radioactive Medical Isotopes Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Radioactive Medical Isotopes Market Size Market Share by Type in 2023
 Figure 31. Carbon-14
 Figure 32. Technetium-99m
 Figure 33. Iodine-131
 Figure 34. Iodine-125
 Figure 35. Others
 Figure 36. World Radioactive Medical Isotopes Market Size Market Share by Type (2019-2030)
 Figure 37. World Radioactive Medical Isotopes Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 38. World Radioactive Medical Isotopes Market Size Market Share by Application in 2023
 Figure 39. Diagnosis
 Figure 40. Treatment
 Figure 41. Others
 Figure 42. World Radioactive Medical Isotopes Market Size Market Share by Application (2019-2030)
 Figure 43. Radioactive Medical Isotopes Industrial Chain
 Figure 44. Methodology
 Figure 45. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom

Related Reports

Global Radioactive Medical Isotopes Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Radioactive Medical Isotopes Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 15 Aug 2024

date Medical Care

According to our (Global Info Research) latest study, the global Radioactive Medical Isotopes market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

Product Tags

Radioactive Medical Isotopes

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>